The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
Open accessAbstract
// Feng Wang 1, * , Hou-Qun Ying 2, * , Bang-Shun He 1 , Yu-Qin Pan 1 , Qi-Wen Deng 1 , Hui-Ling Sun 3 , Jie Chen 3 , Xian Liu 1 , Shu-Kui Wang 1 1 Central Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China 2 Medical college, Southeast University, Nanjing, Jiangsu, China 3 Department of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China * These authors have contributed equally to this work Correspondence to: Shu-Kui Wang, e-mail: shukwangnj@163.com Keywords: hepatocellular carcinoma, lncRNA, UCA1, miR-216b, FGFR1 Received: November 17, 2014 Accepted: January 26, 2015 Published: February 11, 2015 ABSTRACT The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been recently shown to be dysregulated, which plays an important role in the progression of several cancers. However, the biological role and clinical significance of UCA1 in the carcinogenesis of hepatocellular carcinoma (HCC) remain unclear. Herein, we found that UCA1 was aberrantly upregulated in HCC tissues and associated with TNM stage, metastasis and postoperative survival. UCA1 depletion inhibited the growth and metastasis of HCC cell lines in vitro and in vivo . Furthermore, UCA1 could act as an endogenous sponge by directly binding to miR-216b and downregulation miR-216b expression. In addition, UCA1 could reverse the inhibitory effect of miR-216b on the growth and metastasis of HCC cells, which might be involved in the derepression of fibroblast growth factor receptor 1 (FGFR1) expression, a target gene of miR-216b, and the activation of ERK signaling pathway. Taken together, our data highlights the pivotal role of UCA1 in the tumorigenesis of HCC. Moreover, the present study elucidates a novel lncRNA-miRNA-mRNA regulatory network that is UCA1-miR-216b-FGFR1-ERK signaling pathway in HCC, which may help to lead a better understanding the pathogenesis of HCC and probe the feasibility of lncRNA-directed diagnosis and therapy for this deadly disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
Cited by
Bian, Z., Jin, L., Zhang, J., Yin, Y., Quan, C., Hu, Y., Feng, Y., Liu, H., Fei, B., Mao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23892 · Cited by 363
Fu, C., Li, D., Zhang, X., Liu, N., Chi, G., & Jin, X. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0649-9 · Cited by 122
Retracted
Metadata
- Authors
- Wang, F., Ying, H.-Q., He, B.-S., Pan, Y.-Q., Deng, Q.-W., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-02-11
- Volume
- 6
- Issue
- 10
- Pages
- 7899-7917
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1539551850
- Cited by
- 348
- References
- 1
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. https://app.cochat.ai/papers/10.18632/oncotarget.3219
- The paper
- Wang, F., Ying, H.-Q., He, B.-S., Pan, Y.-Q., Deng, Q.-W., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2015). Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. https://doi.org/10.18632/oncotarget.3219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
